105 related articles for article (PubMed ID: 8505808)
1. CA-125 as a screening test for ovarian cancer.
Gocze PM; Freeman DA
JAMA; 1993 Jun 23-30; 269(24):3106-7. PubMed ID: 8505808
[No Abstract] [Full Text] [Related]
2. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
Jacobs IJ; Oram DH; Bast RC
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer screening.
Kurjak A; Predanic M
Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
[TBL] [Abstract][Full Text] [Related]
4. Screening for ovarian cancer: not worthwhile for most patients.
Wong JG; Feussner JR
N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615
[No Abstract] [Full Text] [Related]
5. Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
Bast R; Woolas R
BMJ; 1993 Jun; 306(6893):1684-5. PubMed ID: 8324445
[No Abstract] [Full Text] [Related]
6. Genetic risk and screening techniques for epithelial ovarian cancer. ACOG Committee Opinion: Committee on Gynecologic Practice. Number 117--December 1992.
Int J Gynaecol Obstet; 1993 Jun; 41(3):321-3. PubMed ID: 8102999
[No Abstract] [Full Text] [Related]
7. Ovarian cancer screening: new trial tries new twists.
McNeil C
J Natl Cancer Inst; 1995 Sep; 87(17):1283-5. PubMed ID: 7658479
[No Abstract] [Full Text] [Related]
8. Ovarian cancer screening.
van Nagell JR
Cancer; 1991 Aug; 68(4):679-80. PubMed ID: 1855166
[No Abstract] [Full Text] [Related]
9. Screening for ovarian cancer.
Powell MA
J Am Acad Nurse Pract; 1992; 4(1):36-7. PubMed ID: 1605991
[No Abstract] [Full Text] [Related]
10. Screening for ovarian cancer. Other malignancies cloud the issue.
Clements D
BMJ; 1993 Jun; 306(6893):1685. PubMed ID: 8324446
[No Abstract] [Full Text] [Related]
11. Screening for ovarian cancer. Still controversial, but encouraging.
Wald N; Parkes C
BMJ; 1993 Jun; 306(6893):1684. PubMed ID: 8324444
[No Abstract] [Full Text] [Related]
12. Screening for early ovarian cancer.
Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S
Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556
[TBL] [Abstract][Full Text] [Related]
13. [CA-125: a serum tumor marker in ovarian cancer].
Cohen AD; Piura B; Cohen Y
Harefuah; 1994 Feb; 126(3):154-9. PubMed ID: 8168751
[No Abstract] [Full Text] [Related]
14. A proposal to use CA-125 to evaluate activity of new antineoplastic agents in ovarian cancer.
Markman M
Gynecol Oncol; 1993 Dec; 51(3):297-8. PubMed ID: 8112634
[No Abstract] [Full Text] [Related]
15. [Tumor marker CA 72-4 in ovarian cancer in comparison with CA 125 and D-dimer].
Schelling M; Jänicke F; Senekowitsch R; Lörken A
Gynakol Rundsch; 1991; 31 Suppl 2():286-9. PubMed ID: 1665138
[No Abstract] [Full Text] [Related]
16. Factors influencing serum CA 125 levels in normal women.
Grover S; Quinn MA; Weideman P; Koh H
Obstet Gynecol; 1992 Apr; 79(4):511-4. PubMed ID: 1553167
[TBL] [Abstract][Full Text] [Related]
17. Tumor associated trypsin inhibitor and CA-125 during treatment of mucinous ovarian cancer in 2 patients.
Mogensen O
Eur J Cancer; 1991; 27(9):1180-1. PubMed ID: 1659852
[No Abstract] [Full Text] [Related]
18. Sources of variability in normal CA 125 levels.
Westhoff C; Levin B; Ladd G; O'Connor J
Cancer Epidemiol Biomarkers Prev; 1992; 1(5):357-9. PubMed ID: 1305467
[TBL] [Abstract][Full Text] [Related]
19. Echography and CA 125 in ovarian pathology. Preliminary data of a new score.
Foglia M; Verri PG; Calabrese A; Corongiu F; Tarani A; Margiaria ML; De Pascale A; Tagliati D
J Nucl Med Allied Sci; 1990; 34(4 Suppl):67-70. PubMed ID: 2092152
[No Abstract] [Full Text] [Related]
20. Prospective study of serum CA-125 levels as markers of ovarian cancer.
Helzlsouer KJ; Bush TL; Alberg AJ; Bass KM; Zacur H; Comstock GW
JAMA; 1993 Mar; 269(9):1123-6. PubMed ID: 8433467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
